Ligand Pharmaceuticals
LGND
#2747
Rank
$6.22 B
Marketcap
$312.37
Share price
0.65%
Change (1 day)
76.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of June 2026 : $1.13 Billion USD

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is $1.13 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$0.45 B6276.09%
2024-12-31$7.08 M14.86%
2023-12-31$6.16 M-92.97%
2022-12-31$87.74 M-72.95%
2021-12-31$0.32 B-28.93%
2020-12-31$0.45 B-29.8%
2019-12-31$0.65 B2.18%
2018-12-31$0.63 B183.39%
2017-12-31$0.22 B5.46%
2016-12-31$0.21 B5.41%
2015-12-31$0.20 B3.1%
2014-12-31$0.19 B2050.71%
2013-12-31$9.1 M-67.79%
2012-12-31$28.27 M-6.63%
2011-12-31$30.28 M32.54%
2010-12-31$22.85 M-37%
2009-12-31$36.27 M-29.61%
2008-12-31$51.53 M2291.23%
2007-12-31$2.15 M-94.88%
2006-12-31$42.07 M-75.67%
2005-12-31$0.17 B-0.63%
2004-12-31$0.17 B0.86%
2003-12-31$0.17 B9.66%
2002-12-31$0.15 B10.7%
2001-12-31$0.14 B5.14%
2000-12-31$0.13 B-3.99%
1999-12-31$0.14 B50.27%
1998-12-31$93.7 M72.88%
1997-12-31$54.2 M-4.24%
1996-12-31$56.6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$49.03 B 4,233.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$63.19 B 5,485.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$54.90 B 4,752.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$57.30 B 4,964.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$9.66 B 754.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$53.90 B 4,664.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$45.05 B 3,881.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$24.16 B 2,035.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
$28.84 M-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA